论文部分内容阅读
将初诊2型糖尿病患者92例,分成观察组46例以及对照组46例。其中对照组患者单纯采用二甲双胍治疗;观察组患者在对照组患者基础上给予瑞格列奈。结果:观察组血糖改善明显(P<0.05)。结论:针对于初诊2型糖尿病患者在治疗基础上选择采用二甲双胍联合瑞格列奈治疗其效果优于单纯采用二甲双胍治疗。
92 newly diagnosed type 2 diabetic patients were divided into observation group (46 cases) and control group (46 cases). Patients in the control group were treated with metformin alone; patients in the observation group were given repaglinide on the basis of the control group. Results: The observation group, blood glucose improved significantly (P <0.05). Conclusion: The treatment of patients with newly diagnosed type 2 diabetes treated with metformin and repaglinide is superior to metformin alone.